These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10895372)

  • 1. A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis.
    Herrick AL; Hollis S; Schofield D; Rieley F; Blann A; Griffin K; Moore T; Braganza JM; Jayson MI
    Clin Exp Rheumatol; 2000; 18(3):349-56. PubMed ID: 10895372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Rieley F; Schofield D; Hollis S; Braganza JM; Jayson MI
    J Rheumatol; 1994 Aug; 21(8):1477-83. PubMed ID: 7983650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
    Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
    Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification.
    Butcher GP; Rhodes JM; Walker R; Krasner N; Jackson MJ
    J Hepatol; 1993 Aug; 19(1):105-9. PubMed ID: 8301030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis.
    Herrick AL; Worthington H; Rieley F; Clarke D; Schofield D; Braganza JM; Jayson MI
    J Rheumatol; 1996 Apr; 23(4):650-3. PubMed ID: 8730121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis.
    Kirk GR; White JS; McKie L; Stevenson M; Young I; Clements WD; Rowlands BJ
    J Gastrointest Surg; 2006 Apr; 10(4):499-503. PubMed ID: 16627214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
    Denton CP; Bunce TD; Dorado MB; Roberts Z; Wilson H; Howell K; Bruckdorfer KR; Black CM
    Rheumatology (Oxford); 1999 Apr; 38(4):309-15. PubMed ID: 10378706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.
    Briançon S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S
    Int J Epidemiol; 2011 Dec; 40(6):1605-16. PubMed ID: 22158670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis.
    Schiopu E; Hsu VM; Impens AJ; Rothman JA; McCloskey DA; Wilson JE; Phillips K; Seibold JR
    J Rheumatol; 2009 Oct; 36(10):2264-8. PubMed ID: 19755613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
    Lau CS; Belch JJ; Madhok R; Cappell H; Herrick A; Jayson M; Thompson JM
    Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 6-month multivitamin supplementation on serum concentrations of alpha-tocopherol, beta-carotene, and vitamin C in healthy elderly women.
    Wolters M; Hermann S; Hahn A
    Int J Vitam Nutr Res; 2004 Mar; 74(2):161-8. PubMed ID: 15255454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement.
    Cracowski JL; Girolet S; Imbert B; Seinturier C; Stanke-Labesque F; Bessard J; Boignard A; Bessard G; Carpentier PH
    Free Radic Biol Med; 2005 Jan; 38(1):98-103. PubMed ID: 15589377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial.
    Nyyssönen K; Porkkala E; Salonen R; Korpela H; Salonen JT
    Eur J Clin Nutr; 1994 Sep; 48(9):633-42. PubMed ID: 8001520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
    Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
    Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers?
    Van Hoydonck PG; Schouten EG; Manuel-Y-Keenoy B; van Campenhout A; Hoppenbrouwers KP; Temme EH
    Eur J Clin Nutr; 2004 Dec; 58(12):1587-93. PubMed ID: 15127090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.